This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Goosehead (GSHD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Goosehead (GSHD) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Goosehead Insurance (GSHD) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of 5% and 5.36%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
ZURVY vs. GSHD: Which Stock Is the Better Value Option?
by Zacks Equity Research
ZURVY vs. GSHD: Which Stock Is the Better Value Option?
MURGY vs. GSHD: Which Stock Is the Better Value Option?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
Implied Volatility Surging for Goosehead Insurance (GSHD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Goosehead Insurance (GSHD) stock based on the movements in the options market lately.
MURGY vs. GSHD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
Goosehead (GSHD) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Goosehead (GSHD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Everest Group (EG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Everest Group (EG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MURGY or GSHD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
Goosehead Insurance (GSHD) Earnings Expected to Grow: What to Know Ahead of Q1 Release
by Zacks Equity Research
Goosehead (GSHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Goosehead Insurance (GSHD) Stock?
by Zacks Equity Research
Investors need to pay close attention to Goosehead Insurance (GSHD) stock based on the movements in the options market lately.
MURGY vs. GSHD: Which Stock Is the Better Value Option?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
MURGY vs. GSHD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
MURGY or GSHD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MURGY vs. GSHD: Which Stock Is the Better Value Option?
Goosehead (GSHD) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Goosehead (GSHD) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Goosehead Insurance (GSHD) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of -12.50% and 7.57%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Seeking Clues to Goosehead (GSHD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Goosehead (GSHD) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Corebridge Financial (CRBG) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Corebridge (CRBG) delivered earnings and revenue surprises of 5.05% and 38.08%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Goosehead (GSHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PRU vs. GSHD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PRU vs. GSHD: Which Stock Is the Better Value Option?
AIZ vs. GSHD: Which Stock Is the Better Value Option?
by Zacks Equity Research
AIZ vs. GSHD: Which Stock Is the Better Value Option?
Here's Why EverQuote (EVER) Shares Are Attracting Investors Now
by Zacks Equity Research
EverQuote (EVER) stands to gain from the solid performances of home and renters' insurance, and enhanced capital efficiencies.
Why Old Republic (ORI) Shares Are Attracting Investors Now
by Zacks Equity Research
Old Republic (ORI) stands to gain from higher premiums in commercial auto, financial indemnity and property coverages, and a solid balance sheet.
Aegon (AEG) Plans to Repurchase Shares From Vereniging Aegon
by Zacks Equity Research
Aegon (AEG) enters into an agreement with its majority shareholder, Vereniging Aegon, to participate in a share buyback program.
EG vs. GSHD: Which Stock Is the Better Value Option?
by Zacks Equity Research
EG vs. GSHD: Which Stock Is the Better Value Option?